2 
Others in attendance for all or part of the meeting were; 
William Beisel, tepartment of Defense; Irene Brandt, Eli Lilly & Canpany; Robert 
Brey, Cenex Corporation; Steve Budiamsky, Nature Magazine; Chia T. Chen, OSJA, 
U.S. Department of Labor; Scott Coleridge, Millipore Corporation; Paula Dwyer, 
MoGraw Hill; Gershon Fishbein, Genetic EJigineering Letter; John Galet, 
Schering-Plough Corporation; Richard Geoghegan, E. I. Du Rant De Nemours and 
Ccmpany; TVam M. Helscher, Monsanto Company; Timothy Henry, Health Industry 
Manufacturing Association; Philip Hilts, Weishington Post; Evelyn Hurlburt, 
Johns Hopkins Lhiversity; Dorothy Jessop, U.S. Department of Agriculture; 
Judith A. Johnson, Library of Congress; Mary Jame Johnson, Padl Corporation; 
Attila Kader, F\ood and Drug Administration; Geoffrey Karny, Office of Technology 
Assessment; Michael Larsen, Occupationad Safety & Health Administration; 
Carter LeonauxI, Blue Sheet; D. S. Mabry, Pfizer, Inc.; James McCullough, 
Library of Congress; James Mikulak, State Department; Mary Moore, Millipore 
Corporation; Harvey Price, Industriad Biotechnology Association; Rich Ring, 
Genentech, Inc.; Marvin Rogul, Environmental Protection Agency; Sandra Ronspies, 
Genentech, Inc.; Harold Schmeck, New York Times; Marjory Sun, Science Magazine; 
Charles Turbyville, NIH Vteek; Dave Waureheim, ShiithKline Becknan Corporation; 
and Charles Weiner, Maissachusetts Institute of Technology. 
(461] 
